SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-19-000007
Filing Date
2019-08-02
Accepted
2019-08-02 06:10:18
Documents
96
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-30jun19x10q.htm   iXBRL 10-Q 2672391
2 EXHIBIT 10.1 exhibit101.htm EX-10.1 6488
3 EXHIBIT 10.2 exhibit102.htm EX-10.2 77270
4 EXHIBIT 10.3 exhibit103.htm EX-10.3 172210
5 EXHIBIT 31.1 exhibit311.htm EX-31.1 11006
6 EXHIBIT 31.2 exhibit312.htm EX-31.2 11650
7 EXHIBIT 32.1 exhibit321.htm EX-32.1 6661
  Complete submission text file 0001048477-19-000007.txt   12139258

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20190630.xsd EX-101.SCH 69079
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20190630_cal.xml EX-101.CAL 117218
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20190630_def.xml EX-101.DEF 334455
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20190630_lab.xml EX-101.LAB 851031
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20190630_pre.xml EX-101.PRE 519249
13 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-30jun19x10q_htm.xml XML 2683155
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 19994367
SIC: 2834 Pharmaceutical Preparations